Grant: Discovery Grants Program - Individual
Simon Fraser University
$32,000.00
Marek's disease, a lymphoma caused by herpesvirus-replication dynamics, pathogenesis and vaccine effect
EF 2009-10
Résumé
Marek's disease virus (MDV) causes Marek's disease (MD), a lymphoma of poultry. MDV is globally ubiquitous, thus almost all commercial chickens are vaccinated with the MD vaccine. Incidence of MD in unvaccinated chicken flocks can be as high as 20-30 %; this was commonly observed before the introduction of MD vaccines in the early 1970's. The MD vaccine is unusual in that it does not prevent virulent MDV infection, but rather the vaccine virus prevents tumor formation while co-existing with the virulent virus in the host. The mechanism by which this occurs is not well understood. MD tumor cells harbor the MDV genome, which means the tumor cells are infected with virus. Since MD tumor cells are not killed by the MDV infection, they must be infected latently. Otherwise MDV kills the lytically infected cells. It is very difficult to detect these latently infected cells as MDV makes only a few virus specific proteins and RNAs during latency. However, it is essential to know the dynamics of both lytic and latent infection in order to understand the pathogenesis and vaccination mechanisms in MD.
This proposal strives to reveal the replication dynamics of MDV in infected birds by tagging MDV-infected cells with fluorescent proteins (FPs) that will be used to reveal the relationship between MDV replication dynamics in the body and MD pathogenesis. By carefully selecting the promoters combined with the precise genome modification technology, we will insert FP genes into the MDV genome so that the FPs are expressed in both lytically and latently infected cells in the animal body. By tracking the FP-tagged infected cells, the virus replication dynamics will be easily followed in a bird. Based on this powerful system, we will test the hypothesis that the MD vaccine prevents tumors by reducing the number of latently infected cells.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
356287-2009
Name nom
Niikura, Masahiro
Department département
Health Sciences, Faculty of
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2009
Award amount
32000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
1
Nb partie
5
Application title
Marek's disease, a lymphoma caused by herpesvirus-replication dynamics, pathogenesis and vaccine effect
Keyword
NA
Application summary
Marek's disease virus (MDV) causes Marek's disease (MD), a lymphoma of poultry. MDV is globally ubiquitous, thus almost all commercial chickens are vaccinated with the MD vaccine. Incidence of MD in unvaccinated chicken flocks can be as high as 20-30 %; this was commonly observed before the introduction of MD vaccines in the early 1970's. The MD vaccine is unusual in that it does not prevent virulent MDV infection, but rather the vaccine virus prevents tumor formation while co-existing with the virulent virus in the host. The mechanism by which this occurs is not well understood. MD tumor cells harbor the MDV genome, which means the tumor cells are infected with virus. Since MD tumor cells are not killed by the MDV infection, they must be infected latently. Otherwise MDV kills the lytically infected cells. It is very difficult to detect these latently infected cells as MDV makes only a few virus specific proteins and RNAs during latency. However, it is essential to know the dynamics of both lytic and latent infection in order to understand the pathogenesis and vaccination mechanisms in MD.
This proposal strives to reveal the replication dynamics of MDV in infected birds by tagging MDV-infected cells with fluorescent proteins (FPs) that will be used to reveal the relationship between MDV replication dynamics in the body and MD pathogenesis. By carefully selecting the promoters combined with the precise genome modification technology, we will insert FP genes into the MDV genome so that the FPs are expressed in both lytically and latently infected cells in the animal body. By tracking the FP-tagged infected cells, the virus replication dynamics will be easily followed in a bird. Based on this powerful system, we will test the hypothesis that the MD vaccine prevents tumors by reducing the number of latently infected cells.